Patents by Inventor Lane Desborough

Lane Desborough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12290667
    Abstract: A monitoring feature, such as, for example, a pen cap, for an insulin delivery device may include at least one circuit adapted to detect at least one of a capping or decapping of the pen cap from an insulin pen and a processor for using information to the at least one of a capping or decapping of the pen cap. A monitoring feature for an insulin delivery device includes at least one circuit adapted to detect use of the insulin delivery device.
    Type: Grant
    Filed: June 14, 2022
    Date of Patent: May 6, 2025
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Patent number: 12283361
    Abstract: Some embodiments include burden-free insulin delivery systems and methods. Some embodiments include a method comprising: receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining that the estimated glucose value is approaching or has passed a threshold; and in response to determining that the estimated glucose value is approaching or has surpassed the threshold, not providing an indication to the user through a user interface that the estimated glucose value is approaching or surpassed the threshold.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: April 22, 2025
    Assignee: NUDGE BG, INC.
    Inventor: Lane Desborough
  • Publication number: 20250099680
    Abstract: An insulin delivery monitoring system that includes an insulin delivery device and a controller configured to perform or control performance of operations. A method of insulin delivery includes determining a correction dose of insulin and triggering an alert.
    Type: Application
    Filed: December 9, 2024
    Publication date: March 27, 2025
    Inventors: Bryan Mazlish, Lane Desborough
  • Patent number: 12237063
    Abstract: Some embodiments include burden-free insulin delivery systems and methods. In some embodiments, a method may include receiving previous insulin delivery data at a user device from an insulin pump; receiving estimated glucose data at the user device from a continuous glucose monitor; determining an insulin delivery amount based on the previous insulin delivery data and the estimated glucose data to bring the estimated glucose data closer to a target glucose value without using any user-specific behavioral data physically entered by a user through a user interface of the user device within a previous period of time, the previous period of time being less than six hours; and communicating the insulin delivery amount to the insulin pump.
    Type: Grant
    Filed: May 4, 2022
    Date of Patent: February 25, 2025
    Assignee: Nudge BG, Inc.
    Inventor: Lane Desborough
  • Patent number: 12208251
    Abstract: One or more embodiments of the disclosure relate, generally, to a replacement pen cap for a medication injection pen comprising at least one temperature sensor for monitoring a temperature of a medication, detect dosing events, and determine that medication may be denatured based on temperature data, received analyte measurement data prior, and the detected dosing events.
    Type: Grant
    Filed: December 13, 2021
    Date of Patent: January 28, 2025
    Assignee: Bigfoot Biomedical, Inc.
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20250018113
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to a user provided insulin delivery amount, including a user provided insulin delivery amount that varies from a recommended insulin delivery amount.
    Type: Application
    Filed: July 23, 2024
    Publication date: January 16, 2025
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Publication number: 20250022569
    Abstract: Methods, devices, and systems of delivering infusion fluid (e.g., medication such as insulin) can detect, at multiple times during a dispensation period of time, a pressure level of the infusion fluid in an infusion fluid pathway, either directly or indirectly. Based on the detected pressure levels, one or more actual dispensation times that are after an intended dispensation time can be determined. In some cases, methods, devices, and systems provided herein can use variable occlusion alarm thresholds, which can depend on variables such as an age of an infusion set and/or a current analyte level. In some cases, methods, devices, and systems provided herein can automate medication delivery and use the actual dispensation times in a control algorithm determining medication deliveries.
    Type: Application
    Filed: October 1, 2024
    Publication date: January 16, 2025
    Inventors: Bryan Mazlish, Lane Desborough, Ravi Shankar Rontala Raghunathan
  • Publication number: 20250001091
    Abstract: A method may include displaying at least three icons on a user interface of a mobile device, including a first icon associated with the at least three icons associated with a first carbohydrate level, a second icon associated with the at least three icons associated with a second carbohydrate level, and a third icon associated with the at least three icons associated with a third carbohydrate level. The method may also include receiving a user selection of one of the three icons through the user interface of the mobile device, and determining an insulin bolus level from the user selection. The method may also include communicating the insulin bolus level to an insulin delivery device.
    Type: Application
    Filed: June 18, 2024
    Publication date: January 2, 2025
    Inventors: Lane DESBOROUGH, Bryan MAZLISH, Andrew BOCHENKO, Ross NAYLOR, Jeff BOISSIER, Sabine KABEL-ECKES
  • Patent number: 12161841
    Abstract: An insulin delivery monitoring system that includes an insulin delivery device and a controller configured to perform or control performance of operations. A method of insulin delivery include determining a correction dose of insulin and triggering an alert.
    Type: Grant
    Filed: June 7, 2021
    Date of Patent: December 10, 2024
    Inventors: Bryan Mazlish, Lane Desborough
  • Publication number: 20240350720
    Abstract: One or more embodiments of the disclosure relate, generally, to a pen cap for a manual insulin delivery device. Such a pen cap may include a wireless communication interface, a detection circuit, a user interface, and a processor and memory. The detection circuit may be configured to detect cappings and decappings of the pen cap from a manual insulin delivery device. Timing information and recommendations related to capping and decapping of the pen cap may be presented to a user.
    Type: Application
    Filed: February 12, 2024
    Publication date: October 24, 2024
    Inventors: John SJOLUND, Ambika SRINATH, Andrew BOCHENKO, George CROTHALL, Bryan MAZLISH, Jennifer Martin BLOCK, Sarah MATARESE, Linda MACKOWIAK, Lane DESBOROUGH
  • Patent number: 12106837
    Abstract: Methods, devices, and systems of delivering infusion fluid (e.g., medication such as insulin) can detect, at multiple times during a dispensation period of time, a pressure level of the infusion fluid in an infusion fluid pathway, either directly or indirectly. Based on the detected pressure levels, one or more actual dispensation times that are after an intended dispensation time can be determined. In some cases, methods, devices, and systems provided herein can use variable occlusion alarm thresholds, which can depend on variables such as an age of an infusion set and/or a current analyte level. In some cases, methods, devices, and systems provided herein can automate medication delivery and use the actual dispensation times in a control algorithm determining medication deliveries.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: October 1, 2024
    Assignee: Insulet Corporation
    Inventors: Bryan Mazlish, Lane Desborough, Ravi Shankar Rontala Raghunathan
  • Publication number: 20240307617
    Abstract: One or more embodiments of the disclosure relate, generally, to a diabetes management system. The diabetes management system may include a computing device that is configured to receive data relating to prior insulin use of a user and calculate a sliding scale glucose correction based, at least in part, on the data relating to prior insulin use.
    Type: Application
    Filed: February 8, 2024
    Publication date: September 19, 2024
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20240299657
    Abstract: A multi-modal medicine delivery system in which some embodiments can be configured to control dispensation of medicine according to any of a plurality of delivery modes, such as by closed-loop delivery modes and open-loop delivery modes, and according to a secondary feedback loop to determine user-specific settings related to dosage delivery.
    Type: Application
    Filed: May 2, 2024
    Publication date: September 12, 2024
    Inventors: Bryan Mazlish, Lane Desborough
  • Publication number: 20240299658
    Abstract: Techniques for fluid delivery are provided. In some embodiments, the techniques may involve monitoring a value representative of a physiological condition in a body of a user. The techniques may further involve operating in a first operational mode of a fluid delivery device based on the value representative of the physiological condition. The techniques may further involve transitioning to a second operational mode of the fluid delivery device based at least in part on the value representative of the physiological condition relative to a threshold and a time that has been spent in the first operational mode of the fluid delivery device.
    Type: Application
    Filed: May 14, 2024
    Publication date: September 12, 2024
    Inventors: Cesar C. Palerm, Louis J. Lintereur, Salman Monirabbasi, Kris R. Holtzclaw, Lane Desborough
  • Publication number: 20240299669
    Abstract: Diabetes management systems include an insulin delivery device and a monitoring device for detecting at least one characteristic relating to the insulin delivery device. Monitoring devices may comprise pen caps.
    Type: Application
    Filed: February 6, 2024
    Publication date: September 12, 2024
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Lane Desborough, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak
  • Publication number: 20240293624
    Abstract: One or more embodiments of the disclosure relate, generally, to a system to assist with manual dosing of insulin. Such a system may include a glucose sensor system, a reusable insulin dosing detector, and a recommendation system. The reusable insulin dosing detector may be configured to be reversibly connectable to a disposable component that may form part of an insulin manual delivery assembly. The reusable insulin dosing detector may be configured to detect insulin delivery associated with the insulin manual delivery assembly. The recommendation system may be configured to analyze blood glucose data and determine adjustments to insulin therapy settings.
    Type: Application
    Filed: February 6, 2024
    Publication date: September 5, 2024
    Inventors: John Sjolund, Ambika Srinath, Andrew Bochenko, George Crothall, Bryan Mazlish, Jennifer Martin Block, Sarah Matarese, Linda Mackowiak, Lane Desborough
  • Publication number: 20240261503
    Abstract: A method of insulin delivery, the method may include obtaining one or more blood glucose readings of a user, and, based on the blood glucose readings, generating a set of insulin delivery actions that may include delivery of a baseline basal rate or predefined variations of the baseline basal rate. The method may also include monitoring previous insulin delivery actions to the user to determine whether the previous insulin delivery actions include insulin beyond a threshold amount, where the previous insulin delivery actions may include delivery of the baseline basal rate or predefined variations of the baseline basal rate, and, based on the previous insulin delivery actions including insulin beyond the threshold amount, adjusting the set of insulin delivery actions.
    Type: Application
    Filed: April 17, 2024
    Publication date: August 8, 2024
    Inventors: Bryan Mazlish, Lane Desborough
  • Patent number: 12042630
    Abstract: The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to a user provided insulin delivery amount, including a user provided insulin delivery amount that varies from a recommended insulin delivery amount.
    Type: Grant
    Filed: January 4, 2021
    Date of Patent: July 23, 2024
    Assignee: Insulet Corporation
    Inventors: Bryan Mazlish, Lane Desborough, Ross Naylor
  • Patent number: 12017044
    Abstract: Infusion systems, infusion devices, and related operating methods are provided. An exemplary method of operating an infusion device capable of delivering fluid to a user involves determining a current value for a physiological condition of the user influenced by the fluid violates a first threshold value, determining a predicted value for the physiological condition of the user violates a second threshold value, and automatically altering operation of the infusion device to modify delivery of the fluid to the user after determining the predicted value violates the second threshold value when the current value violates the first threshold value.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: June 25, 2024
    Assignee: Medtronic MiniMed, Inc.
    Inventors: Cesar C. Palerm, Louis J. Lintereur, Salman Monirabbasi, Kris R. Holtzclaw, Lane Desborough
  • Patent number: 11969579
    Abstract: A method of insulin delivery, the method may include obtaining one or more blood glucose readings of a user, and, based on the blood glucose readings, generating a set of insulin delivery actions that may include delivery of a baseline basal rate or predefined variations of the baseline basal rate. The method may also include monitoring previous insulin delivery actions to the user to determine whether the previous insulin delivery actions include insulin beyond a threshold amount, where the previous insulin delivery actions may include delivery of the baseline basal rate or predefined variations of the baseline basal rate, and, based on the previous insulin delivery actions including insulin beyond the threshold amount, adjusting the set of insulin delivery actions.
    Type: Grant
    Filed: June 11, 2021
    Date of Patent: April 30, 2024
    Assignee: Insulet Corporation
    Inventors: Bryan Mazlish, Lane Desborough